Last reviewed · How we verify

NCT04195815

Physical Activity Monitoring in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Completed Last updated 11 May 2021
What this trial tests

trial in Chronic Fatigue Syndrome (CFS) in 27 participants. Completed in 20 November 2020.

Timeline
11 March 2020
Primary endpoint
20 November 2020
20 November 2020

Quick facts

Lead sponsorHaukeland University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment27
Start date11 March 2020
Primary completion20 November 2020
Estimated completion20 November 2020
Sites1 location across Norway

Conditions studied

Sponsor

Haukeland University Hospital

Who can join

Adults 18 to 65, any sex, with Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis (ME). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will assess the feasibility of activity monitoring armbands for continuous measurement of physical activity level in ME/CFS patients, during 6 months follow-up. The main purpose is to assess if continuous measurement of activity level may be incorporated in outcome measures in future clinical interventional trials.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
    Rekeland IG, Sørland K, Bruland O, Risa K, et al · · 2022 · cited 5× · PMID 36121803 · DOI 10.1371/journal.pone.0274472

Verify or expand the search:

Other recruiting trials for Chronic Fatigue Syndrome (CFS)

Currently open trials in the same condition.

Other Haukeland University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04195815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing